Literature DB >> 3466180

Polymorphism of HLA-DR beta chains in DR4, -7, and -9 haplotypes: implications for the mechanisms of allelic variation.

P K Gregersen, T Moriuchi, R W Karr, F Obata, J Moriuchi, J Maccari, D Goldberg, R J Winchester, J Silver.   

Abstract

We have isolated and sequenced cDNA clones corresponding to the DR beta 1 and DR beta 2 loci from two homozygous B-cell lines typed as DR7 (Burkhart) and DR9 (ISK). These nucleotide sequences were compared to beta 1 and beta 2 chains of other DR haplotypes. The first-domain sequences of beta 2 chains are identical in DR4 and DR7 haplotypes. In addition, there is strong sequence homology within the 3' untranslated regions of beta 1 genes from DR4, -7, and -9 haplotypes, thus confirming the close evolutionary relationship among these three haplotypes. In contrast, the first-domain sequences of beta 1 molecules from these haplotypes are very different from each other and do not reflect the DR4, -7, -9 family relationship. Two explanations for the differences in degree of diversity between beta 1 and beta 2 chains are suggested. The differences may be a consequence of selection pressures; this implies functional differences for products of the beta 1 and beta 2 loci. Alternatively, closely linked segments of the human class II region may differ in their underlying rates of variation, independent of selection pressures, and this may in part account for the extraordinary diversity found in the beta 1 first domain.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3466180      PMCID: PMC387092          DOI: 10.1073/pnas.83.23.9149

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  Molecular characterization of MT3 antigens by two-dimensional gel electrophoresis, NH2-terminal amino acid sequence analysis, and southern blot analysis.

Authors:  R Sorrentino; J Lillie; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

2.  Characterization of two distinct DR beta chain alleles at the beta III locus of the DR5 haplotype: beta III alleles are highly conserved.

Authors:  D K Didier; J Schiffenbauer; S Shuman; L F Abruzzini; J Gorski; D L Watling; V L Tieber; B D Schwartz
Journal:  J Immunol       Date:  1986-10-15       Impact factor: 5.422

3.  Structural organization of the DR subregion of the human major histocompatibility complex.

Authors:  T Spies; R Sorrentino; J M Boss; K Okada; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

4.  A general method applicable to the search for similarities in the amino acid sequence of two proteins.

Authors:  S B Needleman; C D Wunsch
Journal:  J Mol Biol       Date:  1970-03       Impact factor: 5.469

5.  Nucleotide sequence of an HLA-DQ alpha chain derived from a DRw9 cell line: genetic and evolutionary implications.

Authors:  J Moriuchi; T Moriuchi; J Silver
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

6.  High-efficiency cloning of full-length cDNA.

Authors:  H Okayama; P Berg
Journal:  Mol Cell Biol       Date:  1982-02       Impact factor: 4.272

7.  Identification of common molecular subsequences.

Authors:  T F Smith; M S Waterman
Journal:  J Mol Biol       Date:  1981-03-25       Impact factor: 5.469

8.  A set of synthetic oligodeoxyribonucleotide primers for DNA sequencing in the plasmid vector pBR322.

Authors:  R B Wallace; M J Johnson; S V Suggs; K Miyoshi; R Bhatt; K Itakura
Journal:  Gene       Date:  1981-12       Impact factor: 3.688

9.  Tracts of high or low sequence divergence in the mouse major histocompatibility complex.

Authors:  M Steinmetz; M Malissen; L Hood; A Orn; R A Maki; G R Dastoornikoo; D Stephan; E Gibb; R Romaniuk
Journal:  EMBO J       Date:  1984-12-01       Impact factor: 11.598

10.  Mutations and selection in the generation of class II histocompatibility antigen polymorphism.

Authors:  K Gustafsson; K Wiman; E Emmoth; D Larhammar; J Böhme; J J Hyldig-Nielsen; H Ronne; P A Peterson; L Rask
Journal:  EMBO J       Date:  1984-07       Impact factor: 11.598

View more
  18 in total

1.  DRw52-group haplotypes are frequent acceptors of DRw15-Dw2 DQ genes in DQA1-DRB1 recombination.

Authors:  P Santamaria; H J Noreen; A L Lindstrom; J J Barbosa; A J Faras; M Segall; S S Rich
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  Molecular analysis of the MHC class II region in DR4, DR7, and DR9 haplotypes.

Authors:  E Kendall; J A Todd; R D Campbell
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

3.  Nomenclature for factors of the HLA system, 1990. The WHO Nomenclature Committee for factors of the HLA system.

Authors: 
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

4.  An aberrant DRB4 null gene transcript is found that could encode a novel HLA-DR beta chain.

Authors:  V R Sutton; R W Knowles
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

5.  Nomenclature for factors of the HLA system, 1989. The WHO Nomenclature Committee.

Authors: 
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

6.  Nomenclature for factors of the HLA system, 1987.

Authors: 
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

7.  Allelic variation in the DR subregion of the human major histocompatibility complex.

Authors:  J I Bell; D Denney; L Foster; T Belt; J A Todd; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

8.  Structural comparison of the genes of two HLA-DR supertypic groups: the loci encoding DRw52 and DRw53 are not truly allelic.

Authors:  J Gorski; P Rollini; B Mach
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

Review 9.  Rheumatoid arthritis genetics: 2009 update.

Authors:  Robert M Plenge
Journal:  Curr Rheumatol Rep       Date:  2009-10       Impact factor: 4.592

10.  HLA gene amplification and hybridization analysis of polymorphism. HLA matching for bone marrow transplantation of a patient with HLA-deficient severe combined immunodeficiency syndrome.

Authors:  L A Baxter-Lowe; J B Hunter; J T Casper; J Gorski
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.